BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  Achillion Announces Proposed Secondary Offering of Common Stock

  Achillion will not sell any shares or receive any proceeds from the offering, and the total number of shares of its outstanding common stock will not change as a result of the offering.

  November 15, 2017

   · 

  3 min read
• Business

  Veritas Pharma Initiates Cancer Research With Dr. Dmitri Petchkovski

  The Company has engaged Dr. Dmitri Petchkovski to specifically investigate lung, prostate, colon, breast, and melanoma cancer cell lines.

  November 15, 2017

   · 

  5 min read
• Biotech Beach

  Mirati Therapeutics Announces Proposed Public Offering of Common Stock

  Mirati today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock. Mirati expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering.

  November 15, 2017

   · 

  4 min read
• BioCapital

  QIAGEN Advances Precision Medicine by Automating Guidelines on Cancer Variants in Industry-Leading QIAGEN Clinical Insight Software

  QIAGEN is launching the QCI enhancements this week at the AMP 2017 Annual Meeting in Salt Lake City, Utah.

  November 15, 2017

   · 

  1 min read
• Business

  Intec Pharma Reports Third Quarter 2017 Operating and Financial Results

  Intec Pharma today announced its third quarter 2017 financial results and provided a corporate update.

  November 15, 2017

   · 

  26 min read
• Biotech Bay

  Agilent Technologies Increases Cash Dividend to 14.9 Cents per Share

  The timing and amounts of future dividends are subject to determination and approval by Agilent’s board.

  November 15, 2017

   · 

  1 min read
• Business

  DalCor Pharma Appoints Dr. Fouzia Laghrissi-Thode to the Board of Directors

  Dr. Laghrissi-Thode is Vice-President at Astra.

  November 15, 2017

   · 

  2 min read
• Business

  Molecular Templates Strengthens Management Team with Appointment of Adam Cutler as Chief Financial Officer

  Mr. Cutler will report to the CEO and will be responsible for all corporate finance, accounting, and investor relations activities.

  November 15, 2017

   · 

  7 min read
• Business

  Evoke Pharma Reports Third Quarter 2017 Results and Highlights

  For the third quarter of 2017, net loss was approximately $5.2 million, or $(0.34) per share, compared to a net loss of approximately $3.0 million, or $(0.29) per share, for the three-month period ended September 30, 2016.

  November 15, 2017

   · 

  8 min read
• Business

  Kane Biotech – Q3 2017 Financial Results, Resignation of Director and Granting of Options

  For the nine months ended September 30, 2017 were $951,634, an increase of 212% compared to $305,271 for the nine months ended September 30, 2016.

  November 15, 2017

   · 

  3 min read